Albireo receives positive chmp opinion for bylvay™ (odevixibat) for treatment of progressive familial intrahepatic cholestasis (pfic)

– bylvay has the potential to become first approved drug to treat all forms of pfic –
ALBO Ratings Summary
ALBO Quant Ranking